Nano-Enabled Combination Therapies Integrating Antioxidants, Peptides, and Hormones for Diabesity Treatment
2026 | NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY (NIJPP) | Pp. 62-69
Obesity and type 2 diabetes frequently coexist as “diabesity,” a chronic condition driven by insulin resistance, βcell stress, lipotoxicity, oxidative damage, and metaflammation. Conventional monotherapies that focus on single pathways often produce incomplet...